DE60023520D1 - Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung - Google Patents
Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtungInfo
- Publication number
- DE60023520D1 DE60023520D1 DE60023520T DE60023520T DE60023520D1 DE 60023520 D1 DE60023520 D1 DE 60023520D1 DE 60023520 T DE60023520 T DE 60023520T DE 60023520 T DE60023520 T DE 60023520T DE 60023520 D1 DE60023520 D1 DE 60023520D1
- Authority
- DE
- Germany
- Prior art keywords
- medical
- controlled release
- solvent
- surgical device
- high visible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0026—Sprayable compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US385107 | 1995-02-07 | ||
US09/385,107 US6413536B1 (en) | 1995-06-07 | 1999-08-27 | High viscosity liquid controlled delivery system and medical or surgical device |
PCT/US2000/023270 WO2001015734A2 (en) | 1999-08-27 | 2000-08-24 | High viscosity liquid controlled delivery system and medical or surgical device |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60023520D1 true DE60023520D1 (de) | 2005-12-01 |
DE60023520T2 DE60023520T2 (de) | 2006-07-27 |
Family
ID=23520037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60023520T Expired - Lifetime DE60023520T2 (de) | 1999-08-27 | 2000-08-24 | Flüssiges hochviskoses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung |
Country Status (9)
Country | Link |
---|---|
US (3) | US6413536B1 (de) |
EP (1) | EP1212092B1 (de) |
JP (2) | JP4276807B2 (de) |
AT (1) | ATE307611T1 (de) |
AU (3) | AU7331900A (de) |
CA (1) | CA2382540C (de) |
DE (1) | DE60023520T2 (de) |
ES (1) | ES2254219T3 (de) |
WO (1) | WO2001015734A2 (de) |
Families Citing this family (139)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7833543B2 (en) * | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
WO2000002564A1 (en) * | 1998-07-10 | 2000-01-20 | The University Of Sydney | Prophylactic treatments of neovascularisation in macular degeneration |
US6565874B1 (en) * | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
AUPQ496500A0 (en) * | 2000-01-06 | 2000-02-03 | University Of Sydney, The | Kit |
AU5911101A (en) * | 2000-04-19 | 2001-10-30 | Genentech Inc | Sustained release formulations |
US8470359B2 (en) | 2000-11-13 | 2013-06-25 | Qlt Usa, Inc. | Sustained release polymer |
US9080146B2 (en) | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
WO2002076344A1 (en) * | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
IL159048A0 (en) * | 2001-06-21 | 2004-05-12 | Genentech Inc | Sustained release formulation |
US7357949B2 (en) * | 2001-12-21 | 2008-04-15 | Agion Technologies Inc. | Encapsulated inorganic antimicrobial additive for controlled release |
US20030118658A1 (en) * | 2001-12-21 | 2003-06-26 | Trogolo Jeffrey A. | High aspect ratio encapsulated inorganic antimicrobial additive for controlled release |
ES2319778T3 (es) * | 2002-03-12 | 2009-05-12 | GALDERMA RESEARCH & DEVELOPMENT | Composiciones que comprenden acido 6-(3-(1-adamantil)-4-metoxifenil)-2-naftanoici para tratamiento de enfermedades dermatologicas. |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
US8075585B2 (en) * | 2002-08-29 | 2011-12-13 | Stryker Corporation | Device and method for treatment of a vascular defect |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
US7344505B2 (en) * | 2002-10-15 | 2008-03-18 | Transoma Medical, Inc. | Barriers and methods for pressure measurement catheters |
US7544674B2 (en) * | 2002-10-25 | 2009-06-09 | Galderma S.A. | Topical skin care composition |
US7354574B2 (en) * | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
JP4865330B2 (ja) * | 2002-12-13 | 2012-02-01 | デュレクト コーポレーション | 経口ドラッグデリバリーシステム |
EP1572164A2 (de) * | 2002-12-18 | 2005-09-14 | Pain Therapeutics, Inc. | Orale dosierungsformen enthaltend medikamentenkerne mit kontrollierter freisetzung und gelatinkapselbeschichtungen mit sofortfreisetzung |
RU2342118C2 (ru) * | 2002-12-19 | 2008-12-27 | Алза Корпорейшн | Стабильные неводные однофазные гели и композиции на их основе для доставки из имплантируемого устройства |
DE10312346A1 (de) * | 2003-03-20 | 2004-09-30 | Bayer Healthcare Ag | Kontrolliertes Freisetzungssystem |
US7776355B2 (en) | 2003-07-03 | 2010-08-17 | Medics Pharmaceutical Corporation | Delivery system for topical medications |
US20050025817A1 (en) * | 2003-07-03 | 2005-02-03 | Bhatia Kuljit S. | Delivery system for topical medications |
EP1696868A1 (de) * | 2003-07-18 | 2006-09-06 | Hill Dermaceuticals, Inc. | Topische hautpflegezusammensetzung mit raffiniertem erdnussöl |
US20070140999A1 (en) * | 2003-07-18 | 2007-06-21 | Hill Dermaceuticals, Inc. | Topical skin care composition containing refined peanut oil |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US20050181018A1 (en) * | 2003-09-19 | 2005-08-18 | Peyman Gholam A. | Ocular drug delivery |
US7087237B2 (en) * | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
US7083803B2 (en) * | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
US20060099173A1 (en) * | 2003-10-24 | 2006-05-11 | Nancy Puglia | Topical skin care composition |
CA2552241C (en) * | 2003-12-30 | 2013-10-01 | Durect Corporation | Co-polymeric devices for controlled release of active agents |
KR20070006708A (ko) * | 2004-01-07 | 2007-01-11 | 트라이머리스 인코퍼레이티드 | HIV gp41 HR2-유래된 합성 펩티드 및 인간 면역결핍바이러스의 전염을 저해하는 치료에서 이들의 용도 |
JP2005220333A (ja) * | 2004-02-03 | 2005-08-18 | Bmg Inc | 生体内分解吸収性高分子及びその製造方法 |
JP2007520496A (ja) * | 2004-02-04 | 2007-07-26 | レットメッド ピーティーワイ リミテッド | 徐放性ステロイド組成物 |
US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
WO2005082380A1 (en) * | 2004-02-26 | 2005-09-09 | Advanced Ocular Systems Limited | Heparin for the treatment of ocular pathologies |
US20050192257A1 (en) * | 2004-02-26 | 2005-09-01 | Peyman Gholam A. | Predictors for patients at risk for glaucoma from steroid therapy |
PL1755616T3 (pl) * | 2004-04-08 | 2014-10-31 | Eye Co Pty Ltd | Leczenie mineralokortykoidami retinopatii wysiękowej |
US20050232876A1 (en) * | 2004-04-19 | 2005-10-20 | Robin Lynn Minga | Skin care compositions |
US20050261243A1 (en) * | 2004-04-21 | 2005-11-24 | Peyman Gholam A | Antiprostaglandins for the treatment of ocular pathologies |
WO2006002067A1 (en) * | 2004-06-15 | 2006-01-05 | Milos Chvapil | Composition and method using local application of lipophilic lathyrogens in sustained release formulations |
US7655682B2 (en) | 2004-07-02 | 2010-02-02 | Medicis Pharmaceutical Corporation | Triple anti-irritant composition |
US7479289B2 (en) * | 2004-07-02 | 2009-01-20 | Medicis Pharmaceutical Corporation | Stable cleanser compositions containing sulfur |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
ES2378671T3 (es) * | 2004-09-17 | 2012-04-16 | Durect Corporation | Composición anestésica local prolongada que contiene SAIB |
US9114162B2 (en) | 2004-10-25 | 2015-08-25 | Celonova Biosciences, Inc. | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
US9107850B2 (en) | 2004-10-25 | 2015-08-18 | Celonova Biosciences, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
KR101153785B1 (ko) | 2004-10-25 | 2012-07-09 | 셀로노바 바이오사이언시스 저머니 게엠베하 | 치료 및/또는 진단용으로 부가할 수 있는 중합체 입자 및이의 제조 및 사용 방법 |
US20210299056A9 (en) | 2004-10-25 | 2021-09-30 | Varian Medical Systems, Inc. | Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
US20060122152A1 (en) * | 2004-12-03 | 2006-06-08 | Peyman Gholam A | Heparin for the treatment of ocular pathologies |
US20060142234A1 (en) * | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension |
WO2006071208A1 (en) * | 2004-12-23 | 2006-07-06 | Durect Corporation | Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh |
WO2007011880A2 (en) | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Enhanced ocular neuroprotection/neurostimulation |
US20070014760A1 (en) * | 2005-07-18 | 2007-01-18 | Peyman Gholam A | Enhanced recovery following ocular surgery |
US20070027105A1 (en) * | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
ES2381631T3 (es) | 2006-02-02 | 2012-05-30 | Synageva Biopharma Corp. | Péptidos inhibidores de la fusión del VIH con propiedades biológicas mejoradas |
ZA200807571B (en) * | 2006-03-01 | 2009-08-26 | Ethypharm Sa | Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion |
EP1854477B9 (de) | 2006-03-16 | 2018-03-14 | Dyax Corp. | Peptid-Inhibitoren von Plasma Kallikrein zur Verwendung in der Behandlung von Augenerkrankungen |
US7458953B2 (en) * | 2006-06-20 | 2008-12-02 | Gholam A. Peyman | Ocular drainage device |
EP2044142A2 (de) | 2006-06-29 | 2009-04-08 | Medtronic, Inc. | Poly(orthoester)polymere sowie herstellungs- und verwendungsverfahren dafür |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
CN101505794B (zh) * | 2006-07-10 | 2013-09-04 | 艾斯巴技术,爱尔康生物医药研究装置有限责任公司 | 穿过上皮和/或内皮层的scFV抗体 |
JP2009542788A (ja) * | 2006-07-12 | 2009-12-03 | コントロールド・セラピューティクス(スコットランド)・リミテッド | クリンダマイシンの塩酸塩を有する薬剤デリバリーポリマー |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
EP2117521B1 (de) * | 2006-11-03 | 2012-06-27 | Durect Corporation | Transdermale abgabesysteme mit bupivacain |
FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
WO2008092084A2 (en) * | 2007-01-26 | 2008-07-31 | Centocor, Inc. | Injectable non-aqueous suspension with high concentration of therapeutic agent |
BRPI0809995A2 (pt) * | 2007-04-03 | 2015-07-21 | Trimeris Inc | Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv |
ES2606951T3 (es) * | 2007-05-18 | 2017-03-28 | Durect Corporation | Formulaciones de liberación prolongada mejoradas |
CN101801415B (zh) | 2007-05-25 | 2015-09-23 | Rb医药品有限公司 | 利培酮化合物的持续递送制剂 |
KR20100080812A (ko) * | 2007-09-25 | 2010-07-12 | 트라이머리스, 인코퍼레이티드 | 치료용 항-hiv 펩티드의 합성 방법 |
CA2705520C (en) * | 2007-11-13 | 2016-06-28 | Surmodics Pharmaceuticals, Inc. | Viscous terpolymers as drug delivery platform |
AU2013202713C1 (en) * | 2007-12-06 | 2015-07-30 | Durect Corporation | Oral pharmaceutical dosage forms |
WO2009088414A2 (en) * | 2007-12-06 | 2009-07-16 | Durect Corporation | Oral pharmaceutical dosage forms |
US20090181068A1 (en) * | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
WO2009100216A1 (en) * | 2008-02-08 | 2009-08-13 | Qps Llc | Composition for sustained release delivery of proteins or peptides |
CA2714514C (en) * | 2008-02-08 | 2016-08-16 | Qps Llc | Non-polymeric compositions for controlled drug delivery |
GB0804619D0 (en) * | 2008-03-12 | 2008-04-16 | Norbrook Lab Ltd | A topical ectoparasiticide composition |
US8956642B2 (en) * | 2008-04-18 | 2015-02-17 | Medtronic, Inc. | Bupivacaine formulation in a polyorthoester carrier |
US8940315B2 (en) * | 2008-04-18 | 2015-01-27 | Medtronic, Inc. | Benzodiazepine formulation in a polyorthoester carrier |
US20090263456A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Methods and Compositions for Reducing Preventing and Treating Adhesives |
JP2011519638A (ja) * | 2008-05-07 | 2011-07-14 | オービージェイ・リミテッド | 経皮拡散促進のための方法および装置 |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
US8822546B2 (en) * | 2008-12-01 | 2014-09-02 | Medtronic, Inc. | Flowable pharmaceutical depot |
US20100143437A1 (en) * | 2008-12-09 | 2010-06-10 | Morris Edward J | Implantable analgesic |
US8951546B2 (en) * | 2008-12-23 | 2015-02-10 | Surmodics Pharmaceuticals, Inc. | Flexible implantable composites and implants comprising same |
US20100168807A1 (en) * | 2008-12-23 | 2010-07-01 | Burton Kevin W | Bioactive terpolymer compositions and methods of making and using same |
US9415197B2 (en) * | 2008-12-23 | 2016-08-16 | Surmodics, Inc. | Implantable suction cup composites and implants comprising same |
US9480643B2 (en) | 2008-12-23 | 2016-11-01 | Surmodics Pharmaceuticals, Inc. | Implantable composites and implants comprising same |
US8974808B2 (en) * | 2008-12-23 | 2015-03-10 | Surmodics, Inc. | Elastic implantable composites and implants comprising same |
EP2488640B1 (de) | 2009-10-14 | 2018-09-26 | Nanyang Technological University | Antiproliferationsmittel |
US9452037B2 (en) | 2010-05-25 | 2016-09-27 | International Scientific Pty Ltd | Delivery of oral care products |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US9463330B2 (en) | 2010-06-17 | 2016-10-11 | International Scientific Pty Ltd | Delivery of skin care products |
WO2012030822A1 (en) | 2010-08-30 | 2012-03-08 | Surmodics Pharmaceuticals, Inc. | Process for reducing moisture in a biodegradable implant device |
ES2549218T3 (es) * | 2011-04-01 | 2015-10-26 | Zhuhai Ortus Biotechnology Co., Ltd. | Material hemostático absorbible para las lesiones óseas y método de preparación asociado |
TW201334791A (zh) * | 2011-11-23 | 2013-09-01 | Durect Corp | 輻射滅菌之可生物降解之藥物遞送組合物 |
NZ725654A (en) | 2012-05-18 | 2018-04-27 | Genentech Inc | High-concentration monoclonal antibody formulations |
US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
KR101768843B1 (ko) | 2013-02-28 | 2017-08-17 | 미라 파마 코포레이션 | 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물 |
US20140308352A1 (en) | 2013-03-11 | 2014-10-16 | Zogenix Inc. | Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material |
CN109602692B (zh) | 2013-03-11 | 2022-11-04 | 度瑞公司 | 包含高粘度液体载体的可注射控制释放组合物 |
EP2983468A4 (de) | 2013-03-15 | 2016-09-07 | Durect Corp | Zusammensetzungen mit rheologiemodifikator zur reduzierung der auflösungsvariabilität |
CA2905132A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with thixotropy and enhanced dissolution reproducibility and stability |
KR102370470B1 (ko) | 2013-03-15 | 2022-03-04 | 헤론 테라퓨틱스 인코포레이티드 | 폴리오르토에스테르 및 비프로톤성 용매의 조성물 |
CA2931547A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
WO2015123734A1 (en) * | 2014-02-21 | 2015-08-27 | The University Of Sydney | Liquid carrier materials |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
WO2015188223A1 (en) | 2014-06-11 | 2015-12-17 | International Scientific Pty Ltd | Device and method to treat or prevent joint degeneration |
CN107249570B (zh) * | 2014-11-21 | 2022-08-09 | 丹麦技术大学 | 用于局部药物释放的凝胶制剂 |
WO2016079331A1 (en) * | 2014-11-21 | 2016-05-26 | Technical University Of Denmark | Gel formulations for enhancing the effect of radiotherapy |
MX2018014087A (es) | 2016-05-20 | 2019-06-10 | Univ Denmark Tech Dtu | Composicion de marcaje palpable. |
JP7258561B2 (ja) | 2016-07-06 | 2023-04-17 | オリエント ファーマ シーオー.,エルティーディー. | 薬物組成物、バリヤー層及び薬物層を有している経口投与形態 |
US11752099B2 (en) * | 2017-03-27 | 2023-09-12 | W. L. Gore & Associates, Inc. | Injectable and biodegradable polymer formulations for controlled release of bioactive agents |
SG11201909478UA (en) | 2017-04-24 | 2019-11-28 | Cocrystal Pharma Inc | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication |
CA3067558A1 (en) | 2017-06-16 | 2018-12-20 | Avery Therapeutics, Inc. | Three dimensional tissue compositions and methods of use |
US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
WO2020023813A1 (en) | 2018-07-27 | 2020-01-30 | Cocrystal Pharma, Inc. | Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication |
TW202023566A (zh) | 2018-09-10 | 2020-07-01 | 美商共結晶製藥公司 | 流感病毒複製之抑制劑 |
EP3866778B1 (de) | 2018-10-17 | 2022-11-30 | Cocrystal Pharma, Inc. | Kombinationen von inhibitoren der influenzavirus-replikation |
US20220048897A1 (en) | 2018-11-26 | 2022-02-17 | Cocrystal Pharma, Inc. | Inhibitors of influenza virus replication |
EP3982922A1 (de) | 2019-06-12 | 2022-04-20 | Technical University of Denmark | Dissacharid-formulierungen zur kontrollierten arzneimittelfreisetzung |
WO2021146215A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
WO2021188620A1 (en) | 2020-03-17 | 2021-09-23 | Cocrystal Pharma Inc. | Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication |
JP2023521116A (ja) | 2020-04-10 | 2023-05-23 | コクリスタル ファーマ,インコーポレイテッド | ノロウイルス及びコロナウイルス複製の阻害剤 |
IL310394A (en) | 2021-08-03 | 2024-03-01 | Cocrystal Pharma Inc | Corona virus inhibitors |
EP4282435A1 (de) | 2022-05-23 | 2023-11-29 | Danmarks Tekniske Universitet | Formulierungen von api's und hilfsstoffen in icells durch hydrophobe ionenpaarung |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2931802A (en) | 1958-04-30 | 1960-04-05 | Eastman Kodak Co | Mixed esters of glucose and sucrose |
GB1088992A (en) | 1963-09-19 | 1967-10-25 | Squibb & Sons Inc | Protective dressings |
US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US3743398A (en) | 1971-03-22 | 1973-07-03 | Eastman Kodak Co | Motion picture projector |
NO139560C (no) | 1972-04-29 | 1979-04-04 | Takeda Chemical Industries Ltd | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater |
CA1030526A (en) | 1973-11-01 | 1978-05-02 | Samuel Wilkinson | Biologically active amides |
DE2438352A1 (de) | 1974-08-09 | 1976-02-26 | Hoechst Ag | Peptidcyclopropylamide mit lh-rh/fshrh-wirkung |
DE2438350C3 (de) | 1974-08-09 | 1979-06-13 | Hoechst Ag, 6000 Frankfurt | Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
JPS55154991A (en) * | 1979-05-23 | 1980-12-02 | Hisamitsu Pharmaceut Co Inc | Beta-d-fructopyranoside derivative |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4530840A (en) | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
DE3716302C2 (de) * | 1987-05-15 | 1996-02-01 | Henkel Kgaa | Verbesserte resorbierbare Knochenwachse und ihre Verwendung |
US4906474A (en) | 1983-03-22 | 1990-03-06 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US4725442A (en) | 1983-06-17 | 1988-02-16 | Haynes Duncan H | Microdroplets of water-insoluble drugs and injectable formulations containing same |
US4622219A (en) | 1983-06-17 | 1986-11-11 | Haynes Duncan H | Method of inducing local anesthesia using microdroplets of a general anesthetic |
US4891225A (en) | 1984-05-21 | 1990-01-02 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
IT1198449B (it) | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | Esteri di alcoli polivalenti di acido ialuronico |
US5391381A (en) | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US5350741A (en) | 1988-07-30 | 1994-09-27 | Kanji Takada | Enteric formulations of physiologically active peptides and proteins |
JPH0296516A (ja) | 1988-09-29 | 1990-04-09 | Dainippon Pharmaceut Co Ltd | 粒剤およびその製造方法 |
US5702716A (en) | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5324520A (en) | 1988-12-19 | 1994-06-28 | Vipont Pharmaceutical, Inc. | Intragingival delivery systems for treatment of periodontal disease |
US5324519A (en) | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
IT1240643B (it) | 1990-05-11 | 1993-12-17 | Mediolanum Farmaceutici Spa | Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano |
US5149543A (en) | 1990-10-05 | 1992-09-22 | Massachusetts Institute Of Technology | Ionically cross-linked polymeric microcapsules |
US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
WO1992017900A1 (en) | 1991-04-03 | 1992-10-15 | Eastman Kodak Company | HIGH DURABILITY MASK FOR DRY ETCHING OF GaAs |
JP3313124B2 (ja) | 1991-07-31 | 2002-08-12 | 森下仁丹株式会社 | 親水性物質を内容物とするシームレスカプセルおよびその製法 |
US5487898A (en) | 1991-08-26 | 1996-01-30 | Abbott Laboratories | Compositions and method for the sublingual or buccal administration therapeutic agents |
YU87892A (sh) | 1991-10-01 | 1995-12-04 | Eli Lilly And Company Lilly Corporate Center | Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu |
AU2605592A (en) | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
ES2136624T3 (es) | 1991-10-21 | 1999-12-01 | Peptech Limited | Implante biocompatible para regular la ovulacion en yeguas. |
DE69432459T2 (de) * | 1993-01-06 | 2003-11-27 | Kinerton Ltd | Ionische molekularkonjugate von bioabbaubaren polyestern und bioaktiven polypeptiden |
US5340572A (en) | 1993-02-08 | 1994-08-23 | Insite Vision Incorporated | Alkaline ophthalmic suspensions |
ES2107203T3 (es) | 1993-03-17 | 1997-11-16 | Minnesota Mining & Mfg | Una formulacion de aerosol que contiene un adyuvante de dispersion derivado de un diol-diacido. |
DE69413955T2 (de) | 1993-03-17 | 1999-04-01 | Minnesota Mining & Mfg | Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel |
DE4322826A1 (de) * | 1993-07-08 | 1995-01-12 | Galenik Labor Freiburg Gmbh | Pharmazeutisches Präparat |
JP3257750B2 (ja) * | 1993-07-20 | 2002-02-18 | エチコン・インコーポレーテツド | ε−カプロラクトンおよびラクチドの液状コポリマー |
JPH07112940A (ja) | 1993-08-26 | 1995-05-02 | Takeda Chem Ind Ltd | 徐放性非経口投与製剤およびその製造方法 |
JPH07115901A (ja) | 1993-10-28 | 1995-05-09 | Fuji Bibaretsuji:Kk | ドコサヘキサエン酸高含有乳化組成物及び飲料 |
EP0739210B1 (de) | 1993-12-29 | 2002-07-24 | Matrix Pharmaceutical, Inc. | Zusammensetzung für lokale freigabe von zytostatika |
PT754032E (pt) | 1994-04-08 | 2002-05-31 | Atrix Lab Inc | Composicoes liquidas para difusao |
US5599852A (en) * | 1994-10-18 | 1997-02-04 | Ethicon, Inc. | Injectable microdispersions for soft tissue repair and augmentation |
US5747058A (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
DE69634277T2 (de) | 1995-06-07 | 2006-01-05 | Southern Biosystems, Inc., Birmingham | Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität |
US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US5968542A (en) | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
JPH10115901A (ja) | 1996-10-09 | 1998-05-06 | Noritsu Koki Co Ltd | 写真現像処理装置 |
DK0959873T3 (da) | 1996-12-20 | 2006-07-03 | Alza Corp | Gelsammensætning og fremgangsmåder |
US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
DE19714765A1 (de) * | 1997-04-10 | 1998-10-15 | Merck Patent Gmbh | Verwendung von niedermolekularen, oligomeren Estern von alpha-Hydroxysäuren und/oder aromatischen o-Hydroxysäuren in kosmetischen Formulierungen |
US5840329A (en) | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
US6051558A (en) | 1997-05-28 | 2000-04-18 | Southern Biosystems, Inc. | Compositions suitable for controlled release of the hormone GnRH and its analogs |
DE19858891A1 (de) * | 1998-12-19 | 2000-06-21 | Merck Patent Gmbh | Verbesserte Knochensiegel |
WO2000078335A1 (en) | 1999-06-18 | 2000-12-28 | Southern Biosystems, Inc. | COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS |
-
1999
- 1999-08-27 US US09/385,107 patent/US6413536B1/en not_active Expired - Lifetime
-
2000
- 2000-08-24 CA CA002382540A patent/CA2382540C/en not_active Expired - Fee Related
- 2000-08-24 AT AT00961358T patent/ATE307611T1/de not_active IP Right Cessation
- 2000-08-24 ES ES00961358T patent/ES2254219T3/es not_active Expired - Lifetime
- 2000-08-24 AU AU73319/00A patent/AU7331900A/en not_active Abandoned
- 2000-08-24 WO PCT/US2000/023270 patent/WO2001015734A2/en active IP Right Grant
- 2000-08-24 DE DE60023520T patent/DE60023520T2/de not_active Expired - Lifetime
- 2000-08-24 EP EP00961358A patent/EP1212092B1/de not_active Expired - Lifetime
- 2000-08-24 JP JP2001520145A patent/JP4276807B2/ja not_active Expired - Lifetime
- 2000-10-26 US US09/699,002 patent/US7053209B1/en not_active Expired - Fee Related
-
2005
- 2005-09-01 AU AU2005205766A patent/AU2005205766A1/en not_active Abandoned
-
2006
- 2006-05-24 US US11/440,642 patent/US20060210599A1/en not_active Abandoned
-
2009
- 2009-01-08 JP JP2009002735A patent/JP2009143935A/ja active Pending
- 2009-04-03 AU AU2009201321A patent/AU2009201321A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1212092B1 (de) | 2005-10-26 |
ES2254219T3 (es) | 2006-06-16 |
CA2382540C (en) | 2009-06-16 |
ATE307611T1 (de) | 2005-11-15 |
CA2382540A1 (en) | 2001-03-08 |
JP4276807B2 (ja) | 2009-06-10 |
WO2001015734A2 (en) | 2001-03-08 |
AU2005205766A1 (en) | 2005-09-29 |
US7053209B1 (en) | 2006-05-30 |
DE60023520T2 (de) | 2006-07-27 |
US20060210599A1 (en) | 2006-09-21 |
WO2001015734A3 (en) | 2001-09-13 |
AU2009201321A1 (en) | 2009-04-23 |
JP2003508449A (ja) | 2003-03-04 |
AU7331900A (en) | 2001-03-26 |
US6413536B1 (en) | 2002-07-02 |
EP1212092A2 (de) | 2002-06-12 |
JP2009143935A (ja) | 2009-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60023520D1 (de) | Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung | |
WO2004052336A3 (en) | High viscosity liquid controlled delivery system and medical or surgical device | |
DE60117043D1 (de) | Behandlung von mukositis | |
BRPI0507680A (pt) | partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas | |
GEP20053427B (en) | Pharmaceutical Compositions Providing Enhanced Drug Concentrations | |
BR0016828A (pt) | Polìmeros superabsorventes | |
AR009301A1 (es) | Procedimiento para preparar un cemento oseo o un material de sustitucion osea que contiene sustancias activas o el correspondiente deposito implantablede liberacion sostenida de farmacos, y un set para preparar un cemento oseo que promueve la liberacion de la sustancia activa | |
ATE406184T1 (de) | Arzneiverabreichungssystem | |
ATE288258T1 (de) | Biodegradierbare polymerzusammensetzung | |
MXPA05003591A (es) | Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos. | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
ATE257386T1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
PT693924E (pt) | Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos | |
BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
FI962154A0 (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
TR200102648T2 (tr) | Büyümeyi destekleyen bileşimler | |
WO2007062060A3 (en) | Methods and compositions using substance p to promote wound healing | |
ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
DE60024414T2 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
ATE505508T1 (de) | Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung | |
SE9603480L (sv) | Beredningsform för svårlösliga läkemedel | |
PL354628A1 (en) | Transdermal delivery of lasofoxifene | |
EA200200914A1 (ru) | Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |